Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Product Reformulation Services

Open
State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for Product Reformulation Services focuses on modifying the chemical compositions of nail products to ensure full compliance with California Department of Toxic Substances Control regulations. The primary objective is to develop new formulas that reduce methyl methacrylate concentrations to below 1,000 ppm while maintaining strict industry performance, efficacy, and safety standards. The scope of work involves the use of specialized laboratory testing equipment and chemical synthesis tools to achieve the required chemical reductions. The final deliverable for this engagement is a reformulated product composition that successfully meets the safety threshold of containing less than 1,000 ppm MMA.

General Info

Subcontract to reformulate nail products to meet California MMA safety regulations.

Agency

California Toxic Substances Control, Department of

Place of Performance

CA

Set-Aside

NONE

Documents

This scope was carved out of R-2023-03R.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Safer Consumer Products: Listing Nail Products Containing Methyl Methacrylate (MMA) at Concentrations Greater Than 1,000 ppm as a Priority Product in Regulation

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Read the full solicitation package

This scope is part of a larger contract. Its documents live on the prime.

  • 1 document on the prime contractFrom Safer Consumer Products: Listing Nail Products Containing Methyl Methacrylate (MMA) at Concentrations Greater Than 1,000 ppm as a Priority Product in Regulation
Read the prime's documents

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyCalifornia Toxic Substances Control, Department of
ContactsNo contacts available
OfficeN/A
Organization / Agency
California Toxic Substances Control, Department of
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Reformulates nail product chemical compositions for manufacturers complying with California Department of Toxic Substances Control (DTSC) regulations. Develops new chemical formulas to reduce MMA concentrations below 1,000 ppm, tests efficacy and safety, and ensures industry performance standards. Uses laboratory testing equipment and chemical synthesis tools. Delivers a reformulated product composition containing <1,000 ppm MMA.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Request for Information (RFI) — NIMHD Population Health and Clinical Research
Solicitation # 75N94027R00005-RFI
The National Institute on Minority Health and Health Disparities (NIMHD), Division of Intramural Research, is issuing a Request for Information (RFI) for Research and Development (R&D) services focused on population health and clinical research to reduce health disparities in the United States. The government intends to establish an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with an anticipated award date of September 2027 and an ordering period of approximately five years. The scope of work includes the development, coordination, and analysis of various research studies, such as population-based cross-sectional surveys, epidemiological studies, clinical trials, and qualitative research. Key requirements include project management, participant recruitment, regulatory support, and the handling of biohazardous materials, with a strong emphasis on compliance with FDA record keeping and reporting standards. This RFI is intended for market research and planning purposes to obtain industry input on a draft Statement of Work and to determine the commercial availability of these services. Interested organizations, regardless of business size, are encouraged to provide feedback on implementation challenges, pricing practices, and alternative approaches. Responses must be submitted electronically to the designated Contract Specialist and Contracting Officer by November 19, 2026. Submissions must include the organization's name, SAM.gov Unique Entity Identifier, physical address, and business size status under NAICS code 541715. This process is not a solicitation for proposals, and no contract award will be made based on the RFI responses.
National Institutes Of Health Olao

POSTED

about 10 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541715
New
Federal
HT9426-27-NOI-049825
Solicitation # HT9426-27-NOI-049825
The Defense Health Agency Contracting Activity, on behalf of the Walter Reed Army Institute of Research, Center for Military Psychiatry and Neuroscience, and the Integrative Systems Biology Branch, intends to negotiate a sole source contract with Mitochon Pharmaceuticals, Inc. under solicitation HT9426-27-NOI-049825. The contractor is required to supply two batches of the proprietary prodrug MP201 for testing Acute Stress Reactions in mice, with target dosages ranging from approximately 8 to 80 mg/kg body weight. Deliverables include the synthesized prodrug, quality control documentation, and dosage background information. Additionally, the contractor will provide informational support to the research team to assist in the preparation of related reports and manuscripts. This action is a Notice of Intent to Sole Source and is not a request for competitive proposals. Interested parties may submit capability statements in PDF, MS Word, or Excel format to Herbert Keen and Lance Nowell by 2:00 p.m. Eastern Time on December 31, 2026, to determine if a competitive procurement is in the government's best interest. No set-aside status has been designated for this requirement. All submissions must be unclassified, and materials provided will not be returned. If no valid responses are received, the agency will proceed with the sole source award to Mitochon Pharmaceuticals, Inc.
Defense Health Agency

POSTED

about 10 hours ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS